| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-07 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-05 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-05 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |